Aldosterone blockade in cardiovascular disease

Heart. 2004 Oct;90(10):1229-34. doi: 10.1136/hrt.2003.025312.

Author

Allan D Struthers¹

Affiliation

¹ Division of Medicine & Therapeutics, Ninewells Hospital & Medical School, Dundee, DD1 9SY, UK. a.d.struthers@dundee.ac.uk

No abstract available

Publication types

Review

MeSH terms

Aldosterone / metabolism*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Animals
Cardiology / education*
Cardiovascular Diseases / drug therapy*
Cardiovascular Diseases / metabolism
Cardiovascular Diseases / pathology
Education, Medical, Continuing
Endothelium, Vascular / metabolism
Fibrosis
Humans
Hyperkalemia / chemically induced
Kidney / metabolism
Mineralocorticoid Receptor Antagonists / adverse effects
Mineralocorticoid Receptor Antagonists / metabolism
Mineralocorticoid Receptor Antagonists / therapeutic use*
Myocardium / metabolism
Myocardium / pathology

Substances

Angiotensin-Converting Enzyme Inhibitors
Mineralocorticoid Receptor Antagonists
Aldosterone